相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial
Ephraim L. Tsalik et al.
LANCET INFECTIOUS DISEASES (2023)
Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs
Tori Kinamon et al.
CLINICAL INFECTIOUS DISEASES (2023)
Which trial do we need? Next-generation sequencing to individualize therapy in Staphylococcus aureus bacteraemia
Ahmad Mourad et al.
CLINICAL MICROBIOLOGY AND INFECTION (2023)
Clinically Adjudicated Reference Standards for Evaluation of Infectious Diseases Diagnostics
Robin Patel et al.
CLINICAL INFECTIOUS DISEASES (2023)
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials
Jessica Howard-Anderson et al.
CLINICAL INFECTIOUS DISEASES (2023)
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study
Jinnethe Reyes et al.
LANCET MICROBE (2023)
The Future Ain't What It Used to Be…Out With the Old…In With the Better: Antibacterial Resistance Leadership Group Innovations
Scott R. Evans et al.
CLINICAL INFECTIOUS DISEASES (2023)
Considerations for the Use of Phage Therapy in Clinical Practice
Gina A. Suh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children The SCOUT-CAP Randomized Clinical Trial
Derek J. Williams et al.
JAMA PEDIATRICS (2022)
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
Minggui Wang et al.
LANCET INFECTIOUS DISEASES (2022)
Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial
Nicholas A. Turner et al.
TRIALS (2022)
Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired Pneumonia
M. M. Pettigrew et al.
MBIO (2022)
Genomic characterization of lytic bacteriophages targeting genetically diverse Pseudomonas aeruginosa clinical isolates
Hayley R. Nordstrom et al.
ISCIENCE (2022)
Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial
Pranita D. Tamma et al.
TRIALS (2022)
Clinical Impact of Ceftriaxone Resistance in Escherichia coli Bloodstream Infections: A Multicenter Prospective Cohort Study
Pranita D. Tamma et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
REPORTing of Antimicrobial Resistance from Blood Cultures (REPORT-ABC), an ARLG Survey Summary: Resistance Marker Reporting Practices from Positive Blood Cultures
Patricia J. Simner et al.
CLINICAL INFECTIOUS DISEASES (2022)
Randomized Trial Evaluating Clinical Impact of RAPid IDentification and Susceptibility Testing for Gram-negative Bacteremia: RAPIDS-GN
Ritu Banerjee et al.
CLINICAL INFECTIOUS DISEASES (2021)
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2021)
Discriminating Bacterial and Viral Infection Using a Rapid Host Gene Expression Test
Ephraim L. Tsalik et al.
CRITICAL CARE MEDICINE (2021)
Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically III Adults in a Phase IV Open-Label Multicenter Study (ACUMIN)
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Average Weighted Accuracy: Pragmatic Analysis for a Rapid Diagnostics in Categorizing Acute Lung Infections (RADICAL) Study
Ying Liu et al.
CLINICAL INFECTIOUS DISEASES (2020)
The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2020)
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
David van Duin et al.
LANCET INFECTIOUS DISEASES (2020)
Therapeutic monitoring of vancomycin for serious -methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)
Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model
Thomas P. Lodise et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Multidrug-Resistant Bacterial Infections in US Hospitalized Patients, 2012-2017
John A. Jernigan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phase I Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants (PROOF)
E Wenzler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
David van Duin et al.
CLINICAL INFECTIOUS DISEASES (2018)
MASTERMIND: Bringing Microbial Diagnostics to the Clinic
Robin Patel et al.
CLINICAL INFECTIOUS DISEASES (2017)
Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?
Steven Marshall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Benefit-risk Evaluation for Diagnostics: A Framework (BED-FRAME)
Scott R. Evans et al.
CLINICAL INFECTIOUS DISEASES (2016)
Host gene expression classifiers diagnose acute respiratory illness etiology
Ephraim L. Tsalik et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing
Ritu Banerjee et al.
CLINICAL INFECTIOUS DISEASES (2015)
Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network
David van Duin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)